By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


OpGen, Inc. 

505 South Rosa Road
Suite 151
Madison  Wisconsin  53719  U.S.A.
Phone: 608-441-8100 Fax:




Company News
OpGen (OPGN) Announces 2017 First Quarter Financial Results 4/27/2017 12:14:40 PM
OpGen (OPGN) Appoints Tina S. Nova, Ph.D. To Board Of Directors 4/27/2017 10:30:45 AM
OpGen (OPGN) Highlights Capabilities Of Its Acuitas Technologies To Rapidly Predict Antibiotic Susceptibility Using Drug Resistance Gene Profiles At ECCMID 4/25/2017 9:47:22 AM
OpGen (OPGN)Announces Date Of First Quarter 2017 Financial Results Conference Call 4/20/2017 10:26:38 AM
OpGen (OPGN) Reports 2016 First Quarter Financial Results And Business Update 5/13/2016 8:15:47 AM
District Of Columbia Hospital Association Chooses OpGen (OPGN) To Create Citywide Effort To Track Multidrug-Resistant Bacteria 11/18/2015 10:47:32 AM
OpGen (OPGN) Reports Third Quarter Financial Results And Provides Business Update 11/13/2015 8:05:37 AM
Data Show “Super Bug” Surveillance System Based On OpGen (OPGN)’s Acuitas Resistome Test Can Identify Potential Outbreaks In Hospitals And Improve Infection Control 10/12/2015 7:33:47 AM
OpGen (OPGN) To Present Data Showing Acuitas Tests Are Effective Tools For Investigating Transmission Of "Super Bugs" 9/22/2015 7:59:08 AM
OpGen (OPGN) Reports Second Quarter Financial Results And Provides Business Update 8/14/2015 10:44:35 AM